Implant for amputated bone having mesh flange for directly connecting prosthesis to skeleton
WO2021071170A2
Portable patient-weighing apparatus
WO2021039298A1
Training data generation device, training data generation program, and training data generation method
WO2021006316A1
Specific marker for identifying t cells specifically attacking cancer cells
WO2021002306A1
Method for determining cancer gene
KR20200064971A
Fucoidan-based Theragnostic Composition
WO2020204574A1
Bidirectional flow control valve and brain disease treatment system comprising same
WO2020204373A2
Apparatus for diagnosing solid cancers and method for providing information on solid cancer diagnosis
KR20200116410A
Device for diagnosing solid tumors and Method for providing information on diagnosing solid tumors
KR20200062083A
A method for screening a therapeutic agent for cancer using binding inhibitor of Cyclin-dependent kinase 1(CDK1) - Cyclin B1
KR102177224B1
Method for cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
WO2020153493A1
Annotation assistance device, annotation assistance method, and annotation assistance program
KR102227735B1
3D Modeling method for organ and 3D organ model
WO2020138385A1
A method for treating swi/snf complex-deficient cancers comprising glutathione (gsh) metabolic pathway inhibitor
KR20200069259A
A composition for promoting oncolytic virus activity or enhancing virus production comprising nc886
WO2020117002A1
Method for predicting prognosis of esophageal squamous cell carcinoma
KR20190132334A
Apparatus attachable to wheelchair for receiving urine bag and wheelchair capable of receiving urine bag
KR20200052223A
Alginate-based injectable hydrogel system
JP2020075122A
Probe for electromyograph, package probe, external instrument connection device for probe, and bio-feedback device
KR20200041806A
Pharmaceutical composition for preventing or treating of cancer comprising Malate Aspartate Shuttle inhibitor and Carnitine Acylcarnitine Carrier Shuttle inhibitor
